{"id":23491,"date":"2025-05-20T08:41:05","date_gmt":"2025-05-20T08:41:05","guid":{"rendered":"https:\/\/makingpharmaindustry.it\/?p=23491"},"modified":"2025-05-20T08:41:05","modified_gmt":"2025-05-20T08:41:05","slug":"64-afi-symposium-pierfelice-ferrari-about-the-first-session","status":"publish","type":"post","link":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-pierfelice-ferrari-about-the-first-session\/","title":{"rendered":"64\u00b0 AFI Symposium | Pierfelice Ferrari about the first session"},"content":{"rendered":"<p class=\"\" data-start=\"61\" data-end=\"213\"><strong data-start=\"61\" data-end=\"213\">Sustainability<\/strong> is an increasingly relevant issue in the <strong>pharmaceutical sector<\/strong>, bringing new challenges and shaping an evolving regulatory landscape.<\/p>\n<p class=\"\" data-start=\"215\" data-end=\"958\">The <strong>first session of the 64th AFI Symposium<\/strong> opens with an overview of the latest international regulations and obligations relevant to 2024 and 2025, including the omnibus package proposed by the European Community at the beginning of 2025, which is currently awaiting approval. This regulation is expected to affect the timing and implementation of several directives. Key directives under discussion include the <strong data-start=\"629\" data-end=\"684\">Corporate Sustainability Reporting Directive (CSRD)<\/strong> and the <strong data-start=\"693\" data-end=\"752\">Corporate Sustainability Due Diligence Directive (CSDD)<\/strong>, with a focus on the concept of <strong data-start=\"785\" data-end=\"807\">double materiality<\/strong>, which evaluates both the company\u2019s environmental and social impact and the external environmental factors that may influence its business activities.<\/p>\n<p class=\"\" data-start=\"960\" data-end=\"1314\">The session will also address the <strong data-start=\"994\" data-end=\"1052\">updated Environmental Risk Assessment (ERA) guidelines<\/strong>, issued in February 2024. These introduce new methodologies for conducting environmental studies and preparing documentation required for regulatory approval during the marketing authorization process of new drugs or significant variations to existing products.<\/p>\n<p class=\"\" data-start=\"1316\" data-end=\"2048\">The second part of the discussion is dedicated to <strong data-start=\"1366\" data-end=\"1408\">company-led sustainability initiatives<\/strong>. <strong data-start=\"1410\" data-end=\"1426\">Chiesi Group<\/strong> will present their roadmap for achieving net zero greenhouse gas emissions, based on an \u201c<strong data-start=\"1516\" data-end=\"1545\">avoid, reduce, compensate<\/strong>\u201d strategy. Similarly, <strong data-start=\"1568\" data-end=\"1581\">GSK Group<\/strong> will share their progress and commitment to their <strong data-start=\"1632\" data-end=\"1660\">net zero nature positive<\/strong> program, outlining methodologies and results. <strong data-start=\"1707\" data-end=\"1726\">Angelini Pharma<\/strong> will introduce the <strong data-start=\"1746\" data-end=\"1764\">Life Green AAP<\/strong> project, co-financed by the EU LIFE program and developed in collaboration with <strong data-start=\"1845\" data-end=\"1866\">Leiden University<\/strong>. This initiative aims to innovate pharmaceutical ingredient production by transitioning from traditional batch processes to more efficient and sustainable continuous flow processes.<\/p>\n<p class=\"\" data-start=\"2050\" data-end=\"2251\">The session will conclude with an <strong data-start=\"2084\" data-end=\"2111\">interactive Q&amp;A segment<\/strong>, allowing participants to engage directly with experts and delve deeper into regulatory frameworks and corporate sustainability strategies.<\/p>\n<p class=\"\" data-start=\"2253\" data-end=\"2423\">\ud83c\udfa5 <strong data-start=\"2256\" data-end=\"2373\">Watch the invitation from Pierfelice Ferrari, Coordinator of the A.F.I. Study Group on Energy and Sustainability.<\/strong><br data-start=\"2373\" data-end=\"2376\" \/>\ud83d\udcc5 <strong data-start=\"2379\" data-end=\"2423\">Save the date: June 11, 2025, in Rimini.<\/strong><\/p>\n<p><iframe loading=\"lazy\" title=\"64\u00b0 AFI Symposium_2025_I Session\" width=\"696\" height=\"392\" src=\"https:\/\/www.youtube.com\/embed\/Y4DZwY6WDlQ?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The first sessione on the 64\u00b0 AFI Symposium is dedicated to Energy &#038; Sustainability: new compliances and real-life cases in the sustainability of the pharmaceutical world: challenges and opportunities<\/p>\n","protected":false},"author":32,"featured_media":23492,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1065],"tags":[],"class_list":{"0":"post-23491","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-afi-interview"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>64\u00b0 AFI Symposium | Pierfelice Ferrari about the first session - MakingPharmaIndustry<\/title>\n<meta name=\"description\" content=\"Energy &amp; Sustainability: new compliances and real-life cases in the sustainability of thepharmaceutical world: challenges and opportunities\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-pierfelice-ferrari-about-the-first-session\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"64\u00b0 AFI Symposium | Pierfelice Ferrari about the first session - MakingPharmaIndustry\" \/>\n<meta property=\"og:description\" content=\"Energy &amp; Sustainability: new compliances and real-life cases in the sustainability of thepharmaceutical world: challenges and opportunities\" \/>\n<meta property=\"og:url\" content=\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-pierfelice-ferrari-about-the-first-session\/\" \/>\n<meta property=\"og:site_name\" content=\"MakingPharmaIndustry\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-20T08:41:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/05\/sessione-I-3.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Valentina Parrella\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Valentina Parrella\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-pierfelice-ferrari-about-the-first-session\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-pierfelice-ferrari-about-the-first-session\/\"},\"author\":{\"name\":\"Valentina Parrella\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/6c2a2cb5a6dc47527ff5eb31dab7d42f\"},\"headline\":\"64\u00b0 AFI Symposium | Pierfelice Ferrari about the first session\",\"datePublished\":\"2025-05-20T08:41:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-pierfelice-ferrari-about-the-first-session\/\"},\"wordCount\":329,\"image\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-pierfelice-ferrari-about-the-first-session\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/05\/sessione-I-3.png\",\"articleSection\":[\"AFI Interview\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-pierfelice-ferrari-about-the-first-session\/\",\"url\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-pierfelice-ferrari-about-the-first-session\/\",\"name\":\"64\u00b0 AFI Symposium | Pierfelice Ferrari about the first session - MakingPharmaIndustry\",\"isPartOf\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-pierfelice-ferrari-about-the-first-session\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-pierfelice-ferrari-about-the-first-session\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/05\/sessione-I-3.png\",\"datePublished\":\"2025-05-20T08:41:05+00:00\",\"author\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/6c2a2cb5a6dc47527ff5eb31dab7d42f\"},\"description\":\"Energy & Sustainability: new compliances and real-life cases in the sustainability of thepharmaceutical world: challenges and opportunities\",\"breadcrumb\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-pierfelice-ferrari-about-the-first-session\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-pierfelice-ferrari-about-the-first-session\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-pierfelice-ferrari-about-the-first-session\/#primaryimage\",\"url\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/05\/sessione-I-3.png\",\"contentUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/05\/sessione-I-3.png\",\"width\":1200,\"height\":800},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-pierfelice-ferrari-about-the-first-session\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/makingpharmaindustry.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"64\u00b0 AFI Symposium | Pierfelice Ferrari about the first session\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#website\",\"url\":\"https:\/\/makingpharmaindustry.it\/en\/\",\"name\":\"MakingPharmaIndustry\",\"description\":\"Luogo di incontro\u00a0per approfondire e discutere le pi\u00f9 importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/makingpharmaindustry.it\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/6c2a2cb5a6dc47527ff5eb31dab7d42f\",\"name\":\"Valentina Parrella\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"caption\":\"Valentina Parrella\"},\"url\":\"https:\/\/makingpharmaindustry.it\/en\/author\/valentina-parrella\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"64\u00b0 AFI Symposium | Pierfelice Ferrari about the first session - MakingPharmaIndustry","description":"Energy & Sustainability: new compliances and real-life cases in the sustainability of thepharmaceutical world: challenges and opportunities","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-pierfelice-ferrari-about-the-first-session\/","og_locale":"en_US","og_type":"article","og_title":"64\u00b0 AFI Symposium | Pierfelice Ferrari about the first session - MakingPharmaIndustry","og_description":"Energy & Sustainability: new compliances and real-life cases in the sustainability of thepharmaceutical world: challenges and opportunities","og_url":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-pierfelice-ferrari-about-the-first-session\/","og_site_name":"MakingPharmaIndustry","article_published_time":"2025-05-20T08:41:05+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/05\/sessione-I-3.png","type":"image\/png"}],"author":"Valentina Parrella","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Valentina Parrella","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-pierfelice-ferrari-about-the-first-session\/#article","isPartOf":{"@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-pierfelice-ferrari-about-the-first-session\/"},"author":{"name":"Valentina Parrella","@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/6c2a2cb5a6dc47527ff5eb31dab7d42f"},"headline":"64\u00b0 AFI Symposium | Pierfelice Ferrari about the first session","datePublished":"2025-05-20T08:41:05+00:00","mainEntityOfPage":{"@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-pierfelice-ferrari-about-the-first-session\/"},"wordCount":329,"image":{"@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-pierfelice-ferrari-about-the-first-session\/#primaryimage"},"thumbnailUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/05\/sessione-I-3.png","articleSection":["AFI Interview"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-pierfelice-ferrari-about-the-first-session\/","url":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-pierfelice-ferrari-about-the-first-session\/","name":"64\u00b0 AFI Symposium | Pierfelice Ferrari about the first session - MakingPharmaIndustry","isPartOf":{"@id":"https:\/\/makingpharmaindustry.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-pierfelice-ferrari-about-the-first-session\/#primaryimage"},"image":{"@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-pierfelice-ferrari-about-the-first-session\/#primaryimage"},"thumbnailUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/05\/sessione-I-3.png","datePublished":"2025-05-20T08:41:05+00:00","author":{"@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/6c2a2cb5a6dc47527ff5eb31dab7d42f"},"description":"Energy & Sustainability: new compliances and real-life cases in the sustainability of thepharmaceutical world: challenges and opportunities","breadcrumb":{"@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-pierfelice-ferrari-about-the-first-session\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-pierfelice-ferrari-about-the-first-session\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-pierfelice-ferrari-about-the-first-session\/#primaryimage","url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/05\/sessione-I-3.png","contentUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/05\/sessione-I-3.png","width":1200,"height":800},{"@type":"BreadcrumbList","@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-pierfelice-ferrari-about-the-first-session\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/makingpharmaindustry.it\/en\/"},{"@type":"ListItem","position":2,"name":"64\u00b0 AFI Symposium | Pierfelice Ferrari about the first session"}]},{"@type":"WebSite","@id":"https:\/\/makingpharmaindustry.it\/en\/#website","url":"https:\/\/makingpharmaindustry.it\/en\/","name":"MakingPharmaIndustry","description":"Luogo di incontro\u00a0per approfondire e discutere le pi\u00f9 importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/makingpharmaindustry.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/6c2a2cb5a6dc47527ff5eb31dab7d42f","name":"Valentina Parrella","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","caption":"Valentina Parrella"},"url":"https:\/\/makingpharmaindustry.it\/en\/author\/valentina-parrella\/"}]}},"_links":{"self":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/23491","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/comments?post=23491"}],"version-history":[{"count":3,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/23491\/revisions"}],"predecessor-version":[{"id":23496,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/23491\/revisions\/23496"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/media\/23492"}],"wp:attachment":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/media?parent=23491"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/categories?post=23491"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/tags?post=23491"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}